Anthony R. Chase, Director at Sarepta Therapeutics, Inc. (SRPT), bought 10,000 shares at $13.95 ($140K) on 2013-11-14, disclosed to the SEC on 2013-11-14.
Open-market purchase of $140k SRPT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| LYB | BUY | 2023-07-10 | $3K | — | Filing → |
| APC | BUY | 2017-05-18 | $200K | — | Filing → |
| APC | BUY | 2014-09-02 | $189K | — | Filing → |